SULLIVAN GREGORY M (Chief Medical Officer) reported 1 transaction at TONIX PHARMACEUTICALS HOLDING CORP.
Review the transaction codes below to understand the nature of each event.
Filed: 2/27/2025ACC: 0001839882-25-011955
Officer· Chief Medical Officer
Since Feb 2026
+58.03K
Net shares
Net buyer
$0.16
Total sold
0
Open market trades
0B · 0S
3
Total transactions
58.03K acquired · 0.11 disposed
Non-Derivative Transactions1
Common Stock, par value $0.001
Direct
Shares
−0.11
Price / share
$1.47
Trade value
$0.16
% of position
New position
2/5/2025
0.11→0.00
Total
Net shares
−0.11
Net value
-$0.16
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.001 Direct | 2/5/2025 | J · J | −0.11 | $1.47 | $0.16 | New position | 0.11 | 0.00 |
| Total | −0.11 | -$0.16 | ||||||
Derivative Transactions2
Stock Option
Direct
Converts to
Common Stock
29.02K shares
Shares
+29.02K
Strike price
8.05
Held after
29.02K
Exercisable
—
2/25/2025
Stock Option
Direct
Converts to
Common Stock
29.02K shares
Shares
+29.02K
Strike price
10.0625
Held after
29.02K
Exercisable
—
2/25/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option Direct | Common Stock29.02K shares | 2/25/2025 | A · Award | +29.02K | 8.05 | — | 29.02K |
| Stock Option Direct | Common Stock29.02K shares | 2/25/2025 | A · Award | +29.02K | 10.0625 | — | 29.02K |